The pharmacovigilance unit evaluates safety information on authorised medicines, for example evaluations of Periodic Safety Update Reports (PSURs) and Risk Management Plans. The unit has intensive contact with the Netherlands Pharmacovigilance Centre Lareb, which, with the use of its database and that of the EU, continuously monitors potential safety problems of medicines. In case of suspicious signals, consultation is held concerning the steps to be taken.
Head of unit
Mrs. dr. Joan (J.G.M.) Deckers